Patent_application_number,Applicant_name,Year_of_application,Patent_system
JP2003052380A,TAKARA HOLDINGS,2003,JPO
JP2003116582A,TAKEDA CHEMICAL INDUSTRIES LTD,2003,JPO
JP2003155298A,SEIKAGAKU CORPORATION,2003,JPO
JP2003159075A,TOSOH CORPORATION,2003,JPO
JP2003180370A,OKAYAMA UNIVERSITY,2003,JPO
JP2003210182A,"RAKUTO KASEI INDUSTRIAL CO LTD, AIST",2003,JPO
JP2003245074A,OKAYAMA UNIVERSITY,2003,JPO
JP2003245075A,OKAYAMA UNIVERSITY,2003,JPO
JP2003304870A,"NANCY SCHOENBRUNNER,THOMAS MYERS,DAVID GELFAND",2003,JPO
JP2003501109A,UNIVERSITY OF UTAH,2003,JPO
JP2003505071A,PROMEGA CORPORATION,2003,JPO
JP2003505082A,ROCHE DIAGNOSTICS,2003,JPO
JP2003506074A,AGILENT TECHNOLOGIES,2003,JPO
JP2003509067A,CNRS,2003,JPO
JP2003510052A,GENECOPOEIA,2003,JPO
JP2003511015A,"BECTON, DICKINSON AND COMPANY",2003,JPO
JP2003511061A,ACTIVE BIOTECH AB,2003,JPO
JP2003512837A,EBARA CORPORATION,2003,JPO
JP2003512859A,MERCK,2003,JPO
JP2003513634A,ACGT PROGENOMICS,2003,JPO
JP2003515525A,"EAST CAROLINA UNIVERSITY,JONATHAN W NYCE",2003,JPO
JP2003516749A,GOVERNMENT OF CHINA,2003,JPO
JP2003517817A,UNIVERSITY OF CALIFORNIA,2003,JPO
JP2003518246A,UNIVERSITY OF CALIFORNIA,2003,JPO
JP2003518923A,MEMORIAL SLOAN-KETTERING CANCER CENTER (US),2003,JPO
JP2003523746A,BASF,2003,JPO
JP2003523769A,VERTEX PHARMACEUTICALS,2003,JPO
JP2003525027A,CEPTYR INC,2003,JPO
JP2003525582A,UNIVERSITY OF UTAH,2003,JPO
JP2003525605A,AGILENT TECHNOLOGIES,2003,JPO
JP2003526327A,"BASSLER L BONNIE,MICHAEL G SURETTE",2003,JPO
JP2003526334A,ENTERPRISE IRELAND (BIORESEARCH IRELAND),2003,JPO
JP2003526364A,"BRUCE J BRYAN,CHRISTOPHER SZENT-GYORGYI,WILLIAM SZCZEPANIAK",2003,JPO
JP2003526608A,THERMO FISHER SCIENTIFIC,2003,JPO
JP2003532698A,PRINCETON UNIVERSITY,2003,JPO
JP2003533178A,UNIVERSITY OF UTAH,2003,JPO
JP2003534774A,CNRS,2003,JPO
JP2003534775A,VERTEX PHARMACEUTICALS,2003,JPO
JP2003535567A,"JOHN W SHULTZ,MARTIN K LEWIS,DONNA LIEPPE,MICHELLE MANDREKAR, DANIEL KEPHART,RICHARD B RHODES,CHRISTINE A ANDREWS, JAMES R HARTNETT, TRENT GU,RYAN J OLSON,KEITH W WOOD,ROY WELCH",2003,JPO